We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+12.33%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$188M
AUM Growth
-$46.8M
(-20%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-31.6%
Top 10 Holdings %
Top 10 Hldgs %
72.79%
Holding
63
New
13
Increased
5
Reduced
5
Closed
15
Top Buys
| 1 |
Medtronic
MDT
|
+$10.4M |
| 2 |
STAAR Surgical
STAA
|
+$9.86M |
| 3 |
Icon
ICLR
|
+$6.74M |
| 4 |
Novavax
NVAX
|
+$6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$5.68M |
Top Sells
| 1 |
Cencora
COR
|
+$31.3M |
| 2 |
GSK
GSK
|
+$23.3M |
| 3 |
Sanofi
SNY
|
+$13.6M |
| 4 |
Centene
CNC
|
+$9.88M |
| 5 |
SkinHealth Systems
SKIN
|
+$7.77M |
Sector Composition
| 1 | Healthcare | 86.21% |
| 2 | Financials | 12.47% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSAC
1
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $23.4M | 12.47% |
2,323,000
| – | – |
|
|
BCYC
2
Bicycle Therapeutics
BCYC
$294M
| $20.2M | 10.78% |
683,425
| – | – |
|
3
Cigna
CI
$80.2B
| $17.4M | 9.29% |
52,611
| – | – |
|
4
Organon & Co
OGN
$3.55B
| $16.4M | 8.75% |
587,836
-41,000
| -7% | -$1.05M |
|
5
United Therapeutics
UTHR
$22.4B
| $15.3M | 8.15% |
54,959
+10,000
| +22% | +$2.52M |
|
|
6
Cencora
COR
$58.8B
| $14M | 7.45% |
84,399
-198,000
| -70% | -$31.3M |
|
|
7
Medtronic
MDT
$102B
| $9.95M | 5.3% |
+128,000
| New | +$10.4M |
|
|
8
STAAR Surgical
STAA
$1.36B
| $7.63M | 4.07% |
+157,129
| New | +$9.86M |
|
|
9
Icon
ICLR
$13B
| $6.6M | 3.52% |
+33,983
| New | +$6.74M |
|
10
Inogen
INGN
$171M
| $5.65M | 3.01% |
286,692
-234,603
| -45% | -$5.05M |
|
11
Avantor
AVTR
$7.71B
| $5.27M | 2.81% |
+250,000
| New | +$5.18M |
|
|
HSKA
12
DELISTED
Heska Corp
HSKA
| $5.24M | 2.79% |
+84,309
| New | +$5.68M |
|
13
Protagonist Therapeutics
PTGX
$8.44B
| $4.74M | 2.53% |
+434,635
| New | +$3.67M |
|
|
14
Novavax
NVAX
$1.38B
| $3.5M | 1.86% |
+340,000
| New | +$6M |
|
|
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
| $3.48M | 1.86% |
555,610
| – | – |
|
16
Pharvaris
PHVS
$2.41B
| $3.21M | 1.71% |
+285,000
| New | +$1.5M |
|
|
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.87M | 1.53% |
+250,000
| New | +$2.06M |
|
18
Orchestra BioMed
OBIO
$221M
| $2.5M | 1.33% |
250,000
| – | – |
|
|
EUCRU
19
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $2.48M | 1.32% |
248,674
| – | – |
|
|
CTIC
20
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.98M | 1.06% |
+330,000
| New | +$1.8M |
|
21
X4 Pharmaceuticals
XFOR
$379M
| $1.81M | 0.97% |
60,865
+13,583
| +29% | +$643K |
|
22
Modular Medical
MODD
$23.3M
| $1.38M | 0.73% |
22,978
+3,833
| +20% | +$345K |
|
|
MRUS
23
DELISTED
Merus
MRUS
| $1.36M | 0.73% |
87,953
| – | – |
|
24
Spyre Therapeutics
SYRE
$8.59B
| $1.35M | 0.72% |
120,198
-66,543
| -36% | -$1.2M |
|
25
Savara
SVRA
$1.17B
| $1.34M | 0.72% |
866,448
+10,020
| +1% | +$13.7K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA